Literature DB >> 6338788

Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome.

G P Wormser, L B Krupp, J P Hanrahan, G Gavis, T J Spira, S Cunningham-Rundles.   

Abstract

Between September 1981 and June 1982, the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia were diagnosed in seven previously healthy young men incarcerated for 5 to 38 months in New York State correctional facilities. All seven patients were anergic, six were lymphopenic, and all developed oral candidiasis. Immunologic evaluation in vitro showed profound defects in cellular immune function in patients tested, with inversion of the normal ratio of helper to suppressor T-cell populations in four of five patients studied. No underlying immunosuppressive disorder was found in any patient, including three patients who had postmortem examinations. Based on these cases, the incidence of this syndrome among inmates of New York State correctional facilities is estimated to be at least 20 out of 100 000 per year. None of the inmates was homosexual but all had used intravenous drugs extensively before incarceration. If intravenous drug use is a cause of the syndrome, then the epidemiologic findings of this study suggest a prolonged incubation period (mean, 14.6 months) before development of serious opportunistic infection. Recognition that certain prisoners are at high risk for the acquired immunodeficiency syndrome has important implications for the prison health-care system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338788     DOI: 10.7326/0003-4819-98-3-297

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission.

Authors:  E Massad; M Rozman; R S Azevedo; A S Silveira; K Takey; Y I Yamamoto; L Strazza; M M Ferreira; M N Burattini; M N Burattini
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  Predictors of reincarceration and disease progression among released HIV-infected inmates.

Authors:  Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

3.  The acquired immunodeficiency syndrome (AIDS).

Authors:  F S Rosen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

4.  Prisoners as medical patients.

Authors:  L B Krupp; E A Gelberg; G P Wormser
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

Review 5.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

6.  Intravenous drug users and the acquired immune deficiency syndrome.

Authors:  H M Ginzburg
Journal:  Public Health Rep       Date:  1984 Mar-Apr       Impact factor: 2.792

Review 7.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

8.  Seroconversion to human immunodeficiency virus in prison inmates.

Authors:  C R Horsburgh; J Q Jarvis; T McArther; T Ignacio; P Stock
Journal:  Am J Public Health       Date:  1990-02       Impact factor: 9.308

9.  Functional T lymphocyte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome.

Authors:  G M Shearer; S M Payne; L J Joseph; W E Biddison
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  HIV infection in the Women's Jail, Orange County, California, 1985 through 1991.

Authors:  G A Gellert; R M Maxwell; K V Higgins; T Pendergast; N Wilker
Journal:  Am J Public Health       Date:  1993-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.